Artiva Biotherapeutics, Inc. (ARTV) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $26.70M | -33.6% |
| 2024 | $40.23M | -24.8% |
| 2023 | $53.50M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $26.70M | -33.6% |
| 2024 | $40.23M | -24.8% |
| 2023 | $53.50M | — |